CD28-IN-4
CD28-IN-4 is a selective CD28 inhibitor with a human IC50 of 231 nM and a human Kd of 344 nM. CD28-IN-4 binds to CD28, disrupts its interaction with CD80, blocks CD28-mediated co-stimulatory signal transduction, and reduces cytokine secretion in a human primary tumor-PBMC and epithelial tissue co-culture model. CD28-IN-4 can be used for cancer-related research.
For research use only. We do not sell to patients.
- CAS No.: 3116073-35-6
- Formula: C19H20ClN5O3
- Molecular Weight:401.85
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
IL-2 |
TNF-α |
In Vitro
CD28-IN-4 (100 μM; 15 min) interacts directly with purified recombinant human CD28 extracellular domain at a concentration of 100 μM, as measured by the Dianthus TRIC assay[1].
CD28-IN-4 (1-10 μM; 48 h) suppresses CD28-dependent T cell activation in a 3D coculture of A549 tumor spheroids and primary human PBMCs, reducing IFN-γ, IL-2, and soluble CD69 levels in a concentration-dependent manner at 1, 5, and 10 μM over 48 h[1].
CD28-IN-4 (1-10 μM; 48 h) inhibits CD28-mediated cytokine production in a coculture of differentiated human MucilAir airway epithelial tissue and primary human PBMCs, reducing IFN-γ, IL-2, and TNF-α levels in a concentration-dependent manner at 1, 5, and 10 μM over 48 h[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:3D coculture of A549 tumor spheroids and primary human PBMCs
-
Concentration:1, 5, 10 μM
-
Incubation Time:48 h
-
Result:Suppressed CD28-dependent T cell activation in a 3D coculture of A549 tumor spheroids and primary human PBMCs.
Reduced IFN-γ, IL-2, and soluble CD69 levels in a concentration-dependent manner.
-
Cell Line:differentiated human MucilAir airway epithelial tissue and primary human PBMCs
-
Concentration:1, 5, 10 μM
-
Incubation Time:48 h
-
Result:Inhibited CD28-mediated cytokine production in a coculture of differentiated human MucilAir airway epithelial tissue and primary human PBMCs.
Reduced IFN-γ, IL-2, and TNF-α levels in a concentration-dependent manner.
Chemical Information
-
CAS No. 3116073-35-6
-
Molecular Weight 401.85
-
Formula C19H20ClN5O3
-
SMILES
ClC1=CN2C(C=C1)=CC(C(N3CC(CN4C=C(CCC(O)=O)N=N4)CC3)=O)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Neuron-Astrocyte Co-culture
Neuron-astrocyte co-culture is used to study how astrocytes regulate neuronal survival, synapse formation, dendritic morphology, neuronal activity, and disease-related neurotoxicity. Indirect “sandwich” or insert-based designs physically separate neurons and astrocytes while allowing soluble astrocyte-derived factors to affect neurons, whereas direct co-culture permits cell-contact and network-level readouts.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)